Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis

被引:258
|
作者
Lehrke, Michael [1 ]
Becker, Alexander [2 ]
Greif, Martin [2 ]
Stark, Renee [3 ]
Laubender, Ruediger P. [4 ]
von Ziegler, Franz [2 ]
Lebherz, Corinna [2 ]
Tittus, Janine [2 ]
Reiser, Maximilian [5 ]
Becker, Christoph [5 ]
Goeke, Burkhard [1 ]
Leber, Alexander W. [2 ]
Parhofer, Klaus G. [1 ]
Broedl, Uli C. [1 ]
机构
[1] Univ Munich, Dept Internal Med 2, D-81377 Munich, Germany
[2] Univ Munich, Dept Internal Med 1, D-81377 Munich, Germany
[3] Helmholtz Zentrum, Munich, Germany
[4] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany
[5] Univ Munich, Dept Radiol, Munich, Germany
关键词
ADIPOKINE; ADIPOCYTE;
D O I
10.1530/EJE-09-0380
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Chemerin is a recently discovered adipokine that regulates adipocyte differentiation and modulates chemotaxis and activation of dendritic cells and macrophages. Given the convergence of adipocyte and macrophage function, chemerin may provide an interesting link between obesity. inflammation and atherosclerosis in humans. We sought to examine the relationship of i) chemerin and markers of inflammation, ii) chemerin and components of the metabolic syndrome. and iii) chemerin and coronary atherosclerotic plaque burden and morphology. Design: Serum chemerin levels were determined in 303 patients with stable typical or atypical chest Pain Who Underwent dual-source multi-slice CT-angiography to exclude coronary artery stenosis. Atherosclerotic plaques were classified its calcified, mixed. or non-calcified. Results: Chemerin levels were highly correlated with high sensitivity C-reactive protein (r=0.44. P<0.0001). interleukin-6 (r=0.18, P=0.002), tumor necrosis factor-alpha. (r=0.24, P<0.0001). resistin (r=0.28. P<0.0001), and leptin r=0.36. P<0.0001) concentrations. Furthermore, chemerin was associated with components of the metabolic syndrome including body mass index (r=0.23, P=0.0002). triglycerides (r=0.29. P<0.0001), HDL-cholesterol (r=-0.18, P=0.003). and hypertension (P<0.0001). In bivariate analysis. chemerin levels were weakly correlated with coronary plaque burden (r=0.16. P=0.006) and the number of non-calcified plaques (r=0.14. P=0.02). These associations, however, were lost after adjusting for established cardiovascular risk factors (odds ratio. OR 1.17, 95%, confidence interval (Cl) 0.97-1.41. P=0.11 for coronary plaque burden: OR 1.06, 95% Cl 0.96-1.17. P=0.22 for non-calcified plaques). Conclusions: Chemerin is strongly associated with markers of inflammation and components of the metabolic syndrome. However, chemerin does not predict coronary, atherosclerosis.
引用
收藏
页码:339 / 344
页数:6
相关论文
共 50 条
  • [41] Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome: the role of markers of inflammation
    Corrado, E.
    Rizzo, M.
    Aluigi, L.
    Patti, A. M.
    Coppola, G.
    Muratori, I.
    Caccamo, G.
    Balasus, F.
    Novo, S.
    INTERNATIONAL ANGIOLOGY, 2012, 31 (03) : 219 - 226
  • [42] Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis
    Chung, Cecilia P.
    Oeser, Annette
    Solus, Joseph F.
    Avalos, Ingrid
    Gebretsadik, Tebeb
    Shintani, Ayurni
    Raggi, Paolo
    Sokka, Tuulikki
    Pincus, Theodore
    Stein, C. Michael
    ATHEROSCLEROSIS, 2008, 196 (02) : 756 - 763
  • [43] Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis
    Badellino, KO
    Wolfe, ML
    Reilly, MP
    Rader, DJ
    PLOS MEDICINE, 2006, 3 (02): : 245 - 252
  • [44] Metabolic syndrome and extension of coronary atherosclerosis
    Pereira, Alexandre C.
    Krieger, Jose E.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 118 (02) : 265 - 266
  • [45] Obesity, metabolic syndrome, and coronary atherosclerosis
    Grundy, SM
    CIRCULATION, 2002, 105 (23) : 2696 - 2698
  • [46] Chemerin is a novel adipokine associated with obesity and metabolic syndrome
    Bozaoglu, K.
    Segal, D.
    Bolton, K.
    McMillan, J.
    Jowett, J.
    Zirmuet, P.
    Collier, G.
    Walder, K.
    DIABETOLOGIA, 2007, 50 : S57 - S57
  • [47] Chemerin is a novel adipokine associated with obesity and metabolic syndrome
    Bozaoglu, Kiymet
    Bolton, Kristy
    McMillan, Janine
    Zimmet, Paul
    Jowett, Jeremy
    Collier, Greg
    Walder, Ken
    Segal, David
    ENDOCRINOLOGY, 2007, 148 (10) : 4687 - 4694
  • [48] Elevated Serum Chemerin Levels are Associated with the Presence of Coronary Artery Disease in Patients with Metabolic Syndrome
    Dong, Baokang
    Ji, Weihua
    Zhang, Yanjun
    INTERNAL MEDICINE, 2011, 50 (10) : 1093 - 1097
  • [49] NEW MARKERS OF INFLAMMATION IN METABOLIC SYNDROME
    Grigore, C.
    Vintila, A. M.
    Stoian, I.
    Grigore, O.
    Dawkins, L.
    Isacoff, D.
    Bruckner, I. V.
    JOURNAL OF HYPERTENSION, 2015, 33 : E244 - E244
  • [50] Gender does not significantly modulate the association between markers of inflammation and the metabolic syndrome
    Saely, C.
    Vonbank, A.
    Rein, P.
    Leiherer, A.
    Drexel, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 (17-18) : 566 - 566